FiercePharmaAsia—Opdivo’s Chinese price; new Novartis Korea chief; GSK Indian consumer sale
admin 24th August 2018 Uncategorised 0Bristol-Myers sets immuno-oncology bar in China by pricing Opdivo at half-price; Novartis brings in new Korean president to see through ongoing kickback allegations; Kellogg and Reckitt are reportedly eyeing GlaxoSmithKline’s Indian consumer business; plus more.
More: FiercePharmaAsia—Opdivo’s Chinese price; new Novartis Korea chief; GSK Indian consumer sale
Source: fierce